July 9, 2024 4:57 PM
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss
Shares in Novo Nordisk, maker of the wildly popular obesity drug Wegovy were down 1.1% on Tuesday after the publication of a data analysis showing rival Eli Lilly's own treatment Mounjaro leads to faster and greater weight loss. The analysis was pub...
